Cargando…

The diagnostic value of circulating microRNAs in heart failure

Heart failure (HF) is a complex clinical syndrome, characterized by inadequate blood perfusion of tissues and organs caused by decreased heart ejection capacity resulting from structural or functional cardiac disorders. HF is the most severe heart condition and it severely compromises human health;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yao-Meng, Li, Wei-Wei, Wu, Jun, Han, Mei, Li, Bing-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364251/ https://www.ncbi.nlm.nih.gov/pubmed/30783473 http://dx.doi.org/10.3892/etm.2019.7177

Ejemplares similares

Prognostic value of microRNAs in heart failure: A meta-analysis
por: Yang, Jie, et al.
Publicado: (2021)

The diagnostic value of circulating microRNAs as a biomarker for gastric cancer: A meta-analysis
por: Wei, Hui, et al.
Publicado: (2019)

Circulating microRNAs and Outcome in Patients with Acute Heart Failure
por: Seronde, Marie-France, et al.
Publicado: (2015)

Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction
por: Li, Ying-Qing, et al.
Publicado: (2013)

Diagnostic value of circulating microRNAs for liver cirrhosis: a meta-analysis
por: Guo, Liwei, et al.
Publicado: (2017)

Circulating MicroRNAs as Biomarkers of Accelerated Sarcopenia in Chronic Heart Failure
por: Qaisar, Rizwan, et al.
Publicado: (2021)

Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
por: Chen, Yei-Tsung, et al.
Publicado: (2019)

Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
por: Hou, Jinpao, et al.
Publicado: (2016)

Desregulated microRNAs in aging-related heart failure
por: Zhuo, Ran, et al.
Publicado: (2014)

MicroRNAs in heart and circulation during physical exercise
por: Wang, Lijun, et al.
Publicado: (2018)

The diagnostic value of circulating microRNAs as biomarkers for coronary artery disease: A meta-analysis
por: Fang, Qin, et al.
Publicado: (2020)

PlasmiR: A Manual Collection of Circulating microRNAs of Prognostic and Diagnostic Value
por: Tastsoglou, Spyros, et al.
Publicado: (2021)

Circulating microRNAs as potential diagnostic biomarkers for osteoporosis
por: Mandourah, Abdullah Y., et al.
Publicado: (2018)

Circulating Exosome microRNAs as Diagnostic Biomarkers of Dementia
por: Dong, Xiaoyu, et al.
Publicado: (2020)

Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism
por: MacKenzie, Scott M., et al.
Publicado: (2021)

MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure
por: Dubois-Deruy, Emilie, et al.
Publicado: (2017)

Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure
por: Abu-Halima, Masood, et al.
Publicado: (2017)

Identification of novel circulating microRNAs in advanced heart failure by next‐generation sequencing
por: Galluzzo, Alessandro, et al.
Publicado: (2021)

MicroRNAs: diagnostic, prognostic and therapeutic role in heart failure—a review
por: Gargiulo, Paola, et al.
Publicado: (2022)

Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
por: Yao, Yunjin, et al.
Publicado: (2021)

Circulating MicroRNAs: Potential Biomarkers for Cancer
por: Yu, De-Cai, et al.
Publicado: (2011)

Diagnostic and Predictive Values of Circulating Extracellular Vesicle-Carried microRNAs in Ischemic Heart Disease Patients With Type 2 Diabetes Mellitus
por: Zhang, Li, et al.
Publicado: (2022)

Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer
por: Peng, Cheng, et al.
Publicado: (2021)

Diagnostic Utility and Pathogenic Role of Circulating MicroRNAs in Vasospastic Angina
por: Park, Chan Soon, et al.
Publicado: (2020)

Circulating MicroRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure
por: Gao, Guangyuan, et al.
Publicado: (2019)

Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10 years survival
por: Wagh, Vilas, et al.
Publicado: (2023)

Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis
por: Yao, Can, et al.
Publicado: (2018)

Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease
por: Zhang, Lei, et al.
Publicado: (2019)

May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?
por: Wu, Xiaoling, et al.
Publicado: (2015)

Circulating MicroRNAs as Diagnostic Biomarkers for Motor Neuron Disease
por: Wang, Lin, et al.
Publicado: (2020)

The diagnostic value of circulating microRNAs for middle-aged (40–60-year-old) coronary artery disease patients
por: Md Sayed, Ali Sheikh, et al.
Publicado: (2015)

Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease
por: Yang, Yimin, et al.
Publicado: (2021)

Circulating microRNAs in aging
por: Bonafè, Massimiliano, et al.
Publicado: (2015)

Circulating microRNAs in Medicine
por: Pozniak, Tetiana, et al.
Publicado: (2022)

Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs
por: Oerlemans, Martinus I F J, et al.
Publicado: (2012)

Diagnostic Value of Circulating microRNAs for In-Stent Restenosis in Patients with Lower Extremity Arterial Occlusive Disease
por: Yuan, Liangxi, et al.
Publicado: (2019)

The Potential Diagnostic and Prognostic Value of Circulating MicroRNAs in the Assessment of Patients With Prostate Cancer: Rational and Progress
por: Samami, Elham, et al.
Publicado: (2022)

Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure
por: Dubois-Deruy, Emilie, et al.
Publicado: (2018)

Corrigendum to “Circulating microRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure”
por: Gao, Guangyuan, et al.
Publicado: (2022)

The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
por: Jiang, Yao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4h0alfoha57te2k271m01ff2p3